Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry - PubMed (original) (raw)
Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry
M Ponz de Leon et al. Cancer. 1993.
Abstract
Background: Hereditary nonpolyposis colorectal cancer (HNPCC or Lynch syndrome) is an autosomal dominant disease characterized by early-onset intestinal neoplasms, localization of tumors in the proximal colon, and frequent association with cancers at other sites, especially the endometrium, skin, and stomach. The identification of HNPCC is often difficult, owing to the lack of biomarkers and the extreme frequency of sporadic colorectal cancer in the Western World.
Methods: The authors reviewed the clinical data and the family trees of all patients (n = 817) with colorectal malignancies registered in the local health district between 1984-1989 with the following objectives: (1) to identify families with HNPCC and (2) to establish the frequency of the syndrome in northern Italy. Six clinical criteria were defined (vertical transmission, familial aggregation, early age at onset, right colon localization, multiple tumors, and mucinous carcinoma), all indicative of an increased possibility of HNPCC:
Results: The registered families were divided into various subgroups according to the presence (in the nuclear pedigree) of four or more criteria (41 families, 5.0% of total), three criteria (58 families, 7%), two criteria (73, 8.9%), or less than two criteria (203 families, 24.8%). The remaining 380 case families did not show criteria suggesting a genetic component. One hundred thirty-three genealogic trees were extended further to gather information on second-degree and third-degree relatives. The expanded pedigrees were further analyzed to ascertain if they met the recently proposed requisites for HNPCC: Nineteen of 37 (51%) families with four criteria met the minimum requisites and could therefore be considered HNPCC: Similarly, HNPCC was diagnosed in six extended pedigrees of the three-criteria (16.6%) and in three families (8.5%) of the two-criteria subgroups. The difference in the detection of HNPCC among various subgroups was statistically significant (P < 0.001). From the observed findings, the frequency of HNPCC in this population can be estimated to be between 3.4-4.5% of all cases of colorectal cancer.
Conclusions: HNPCC can be identified in the general population through the data of a colorectal cancer registry if the nuclear pedigrees of all incident cases are traced and a proportion of them selectively expanded. The observed frequency of HNPCC was rather consistent with previous estimates in other populations.
Similar articles
- Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.
Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, Toshihiko Nakagawa W, Aguilar S Jr, Monteiro Santos EM, Vierira Costa ML, Lopes A. Oliveira Ferreira F, et al. Fam Cancer. 2004;3(1):41-7. doi: 10.1023/B:FAME.0000026810.99776.e9. Fam Cancer. 2004. PMID: 15131405 - Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
de Leon MP, Pedroni M, Benatti P, Percesepe A, Di Gregorio C, Foroni M, Rossi G, Genuardi M, Neri G, Leonardi F, Viel A, Capozzi E, Boiocchi M, Roncucci L. de Leon MP, et al. Gut. 1999 Jul;45(1):32-8. doi: 10.1136/gut.45.1.32. Gut. 1999. PMID: 10369701 Free PMC article. - Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in northern Italy. Colorectal Cancer Study Group.
Benatti P, Sassatelli R, Roncucci L, Pedroni M, Fante R, Di Gregorio C, Losi L, Gelmini R, Ponz de Leon M. Benatti P, et al. Int J Cancer. 1993 May 28;54(3):371-7. doi: 10.1002/ijc.2910540304. Int J Cancer. 1993. PMID: 8509211 - Descriptive epidemiology of hereditary non-polyposis colorectal cancer.
Ponz de Leon M. Ponz de Leon M. Tumori. 1996 Mar-Apr;82(2):102-6. doi: 10.1177/030089169608200202. Tumori. 1996. PMID: 8644370 Review. - Prevalence of hereditary nonpolyposis colorectal carcinoma (HNPCC).
Ponz de Leon M. Ponz de Leon M. Ann Med. 1994 Jun;26(3):209-14. doi: 10.3109/07853899409147892. Ann Med. 1994. PMID: 8074839 Review.
Cited by
- Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy.
Masci D, Puxeddu M, Silvestri R, La Regina G. Masci D, et al. Molecules. 2024 May 2;29(9):2110. doi: 10.3390/molecules29092110. Molecules. 2024. PMID: 38731601 Free PMC article. Review. - Emerging Therapeutic Agents for Colorectal Cancer.
Nalli M, Puxeddu M, La Regina G, Gianni S, Silvestri R. Nalli M, et al. Molecules. 2021 Dec 9;26(24):7463. doi: 10.3390/molecules26247463. Molecules. 2021. PMID: 34946546 Free PMC article. Review. - Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.
Liu J, Dong C, Jiang G, Lu X, Liu Y, Wu H. Liu J, et al. BMC Med Genomics. 2020 Sep 21;13(Suppl 9):135. doi: 10.1186/s12920-020-00775-0. BMC Med Genomics. 2020. PMID: 32957968 Free PMC article. - The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism.
Rigas B, Tsioulias GJ. Rigas B, et al. J Pharmacol Exp Ther. 2015 Apr;353(1):2-8. doi: 10.1124/jpet.114.220806. J Pharmacol Exp Ther. 2015. PMID: 25589413 Free PMC article. Review. - Colorectal cancer: chemopreventive role of curcumin and resveratrol.
Patel VB, Misra S, Patel BB, Majumdar AP. Patel VB, et al. Nutr Cancer. 2010;62(7):958-67. doi: 10.1080/01635581.2010.510259. Nutr Cancer. 2010. PMID: 20924971 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous